Sunday, 19 April 2026
  
Login

Australia's most trusted
source of pharma news

Sunday, 19 April 2026
News

GSK entangled in fraud claim

Posted 28 July 2025 PM

GSK has fired back at a scathing report published by Nine Newspapers raising questions about the science underpinning the company's pipeline cancer drug nelistotug, which is currently under trial.

The news outlet claims to have spoken with 20 people - almost all on the condition of anonymity - who alleged academic research had been fabricated and falsified, sparking concerns that the drug "may not work as intended".

To see the whole article, please login

Popular

Pfizer names local as Interim MD
Patient fury over pricing standoff
Time for a tough conversation
New hurdle for Novartis therapy
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (4)

Sales & Customer Relations (14)

Clinical & Medical, R&D (8)

Regulatory, Pharmacovigilance & QA (3)

Other (8)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home